GB1582224A - Apparatus for the preparation of a fluid for examination in optical analytic instruments - Google Patents
Apparatus for the preparation of a fluid for examination in optical analytic instruments Download PDFInfo
- Publication number
- GB1582224A GB1582224A GB19197/78A GB1919778A GB1582224A GB 1582224 A GB1582224 A GB 1582224A GB 19197/78 A GB19197/78 A GB 19197/78A GB 1919778 A GB1919778 A GB 1919778A GB 1582224 A GB1582224 A GB 1582224A
- Authority
- GB
- United Kingdom
- Prior art keywords
- capillary tube
- sample
- reaction solution
- vessel
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 17
- 239000012530 fluid Substances 0.000 title claims description 37
- 238000002360 preparation method Methods 0.000 title description 2
- 238000006243 chemical reaction Methods 0.000 claims abstract description 58
- 239000000376 reactant Substances 0.000 claims abstract description 20
- 239000007790 solid phase Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 43
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 34
- 210000004369 blood Anatomy 0.000 claims description 31
- 239000008280 blood Substances 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 26
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 24
- 210000002966 serum Anatomy 0.000 claims description 22
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 15
- 102000003992 Peroxidases Human genes 0.000 claims description 13
- 229940088598 enzyme Drugs 0.000 claims description 13
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 235000012000 cholesterol Nutrition 0.000 claims description 12
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 11
- 229950006238 nadide Drugs 0.000 claims description 11
- 108090000371 Esterases Proteins 0.000 claims description 10
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 10
- 229960001231 choline Drugs 0.000 claims description 10
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 10
- 108010015776 Glucose oxidase Proteins 0.000 claims description 9
- 239000004366 Glucose oxidase Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 230000002255 enzymatic effect Effects 0.000 claims description 9
- 229940116332 glucose oxidase Drugs 0.000 claims description 9
- 235000019420 glucose oxidase Nutrition 0.000 claims description 9
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 8
- NYBKRNICRGLHMH-UHFFFAOYSA-M 2,5-dichlorobenzenediazonium;chloride Chemical compound [Cl-].ClC1=CC=C(Cl)C([N+]#N)=C1 NYBKRNICRGLHMH-UHFFFAOYSA-M 0.000 claims description 7
- NTBLZMAMTZXLBP-UHFFFAOYSA-M 2-acetylsulfanylethyl(trimethyl)azanium;iodide Chemical compound [I-].CC(=O)SCC[N+](C)(C)C NTBLZMAMTZXLBP-UHFFFAOYSA-M 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 6
- 108010089254 Cholesterol oxidase Proteins 0.000 claims description 5
- 108010046301 glucose peroxidase Proteins 0.000 claims description 5
- 108010055297 Sterol Esterase Proteins 0.000 claims description 4
- 102000000019 Sterol Esterase Human genes 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 239000008055 phosphate buffer solution Substances 0.000 claims description 4
- AWDBHOZBRXWRKS-UHFFFAOYSA-N tetrapotassium;iron(6+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] AWDBHOZBRXWRKS-UHFFFAOYSA-N 0.000 claims description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 241000252095 Congridae Species 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 239000012491 analyte Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- DSARFWXDKCYNNI-UHFFFAOYSA-N methanol;phenol Chemical compound OC.OC1=CC=CC=C1 DSARFWXDKCYNNI-UHFFFAOYSA-N 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 2
- 235000011009 potassium phosphates Nutrition 0.000 claims description 2
- 238000005259 measurement Methods 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 5
- 238000005375 photometry Methods 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 71
- 239000003153 chemical reaction reagent Substances 0.000 description 60
- 239000011521 glass Substances 0.000 description 37
- 239000004033 plastic Substances 0.000 description 37
- 229920003023 plastic Polymers 0.000 description 37
- 238000012360 testing method Methods 0.000 description 31
- 238000004458 analytical method Methods 0.000 description 19
- 230000008033 biological extinction Effects 0.000 description 18
- 210000002381 plasma Anatomy 0.000 description 16
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 8
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000007654 immersion Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 5
- 102000020006 aldose 1-epimerase Human genes 0.000 description 5
- 108091022872 aldose 1-epimerase Proteins 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- MPHSORCNUGSJAA-UHFFFAOYSA-N 2,5-dichlorobenzenediazonium Chemical class ClC1=CC=C(Cl)C([N+]#N)=C1 MPHSORCNUGSJAA-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000005030 aluminium foil Substances 0.000 description 3
- 239000012954 diazonium Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 230000002489 hematologic effect Effects 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 229960005222 phenazone Drugs 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 108010036302 hemoglobin AS Proteins 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- CTGNYPVJSIRPLG-UHFFFAOYSA-N trimethyl(2-sulfanylethyl)azanium;iodide Chemical compound [I-].C[N+](C)(C)CCS CTGNYPVJSIRPLG-UHFFFAOYSA-N 0.000 description 2
- ICVRSZZKVKXKIV-UHFFFAOYSA-M 2,6-dichlorobenzenediazonium;chloride Chemical compound [Cl-].ClC1=CC=CC(Cl)=C1[N+]#N ICVRSZZKVKXKIV-UHFFFAOYSA-M 0.000 description 1
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 101100080807 Drosophila melanogaster mt:ND2 gene Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 101150016680 MT-ND2 gene Proteins 0.000 description 1
- 102100028488 NADH-ubiquinone oxidoreductase chain 2 Human genes 0.000 description 1
- 101150102231 ND2 gene Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- ZPNKIIKAXNCFKF-UHFFFAOYSA-N [I+].CC(=O)SCC[N+](C)(C)C Chemical compound [I+].CC(=O)SCC[N+](C)(C)C ZPNKIIKAXNCFKF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- BYGOPQKDHGXNCD-UHFFFAOYSA-N tripotassium;iron(3+);hexacyanide Chemical compound [K+].[K+].[K+].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] BYGOPQKDHGXNCD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Optical Measuring Cells (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
The measuring liquid in analytical optical devices frequently has to be treated prior to the measurement. A device suitable for this purpose is based on an optical cuvette (cell) filled with a suitable reaction solution. The sample liquid is dispensed into the reaction solution with the aid of a capillary. Normally, all the reactants for the reaction are contained in the reaction solution along with the sample liquid. In the case of the device described here, however, some of the reactants are only introduced into the reaction solution using the dispensing capillary. For this purpose, the dispensing capillary, or independently thereof an additional capillary, is filled with the reactant in the solid phase. When the sample liquid and the reactant are mixed with the reaction solution in the capillary, a chemical reaction sets in which results in a characteristic change in the optical absorption. This change serves as a basis for a photometric measurement.
Description
(54) AN APPARATUS FOR THE PREPARATION
OF A FLUID FOR EXAMINATION IN OPTICAL
ANALYTIC INSTRUMENTS
(71) We BAYER AKTENGESELLSCHAFT a body corporate organised under the laws of
Germany of 509 Leverkusen, Germany do hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement:
The invention relates to an apparatus for preparing a fluid for examination in optical analytic instruments and is based on a sealed vessel filled with an accurately prepared reaction solution and a capillary tube which may introduced into the vessel for dispensing the sample fluid into the reaction solution. The invention is applicable in particular to the analytical examination of body fluids.
"Ready tests" are increasingly offered in the sphere of haematological, clinico-chemical and biochemical investigations and these "ready tests" allow the user to rapidly and easily determine haematological, clinico-chemical and bio-chemical parameters without even having to add reagents.
These "ready tests", also known as "monotests", "single-tests" or "single glass tests", are characterised in that unstable components of the reagent which is ready for use may be stored usually in freeze-dried form in glass or plastic containers.
Before the reagent is ready for use, a solvent which may contain still further substances required for the complete reagent is added.
In some cases, for example in the determination of haemoglobin, the reagent, which is ready for use, may be present in the glass or plastic container.
The sample to be analysed e.g. fluid, blood, plasma or serum, is then added to the prepared reagent usually by means of a pipette so as to guarantee accurate dispensing. The reagentsample mixture is subsequently conveyed to a measuring vessel, usually a glass or quartz, and is analysed in a measuring instrument, for example a photometer.
Sealable vessels have recently been disclosed (German Offenlegungsschrift No. 2,422,260) which are designed as plastics single use measuring vessels (preferably composed of polystyrene) and are hermetically sealed by means of a plastic cover.
In this case, the cover is joined to the vessel by bonding, for example, by means of ultrasonics during mass production. The cover has a predetermined point for fracture, which may be broken by means of a pin. The sample to be analysed may be introduced into the vessel through the opening thus produced in the vessel cover.
The vessel itself already contains the complete reagent fluid. In photometric determination fo the erythrocytes number, for example, it is only necessary for the user to introduce 5 ul of blood into the vessel through the opening in the cover using a volume-calibrated glass capillary tube.
Photometric measurement may take place as soon as the blood has mixed completely with the reagent. This method is particularly good because the user has neither to add nor to dissolve the reagent, nor does he require auxiliary instruments for the analysis such as pipettes. This simplifies analysis considerably so that it may be carried out correctly by people who have not been specially trained.
The previously known methods described have the following disadvantages:
During the "ready tests" it is still usually necessary to make transfers using a pipette.
Expensive and sensitive auxiliary instruments such as, for example, Eppendorf-Pipettes are required for this purpose. The using of a pipette itself represents a source of error.
The solvent required, for example, distilled water, is not always available in the quality demanded (for example quartz-distilled water).
The complete reagent or the complete reagent-sample mixture still has to be conveyed into a measuring vessel, for example a glass vessel, before the actual measuring can take place. This is an additional operating stage which provides the further possibility the introduction of errors, such as, for example, vessels which are not completely clean or not completely dry (producing errors in volume) or residues or detergents in the vessels. In all, the carry8ing out of these "ready tests" is so complicated that they may not justifiably be called "ready tests" and there is such a large number of sources of error that these cannot be carried out by people who have not been specially trained.
The test described in German Offenlegungsschrift No. 2,422,260 substantially meets the requirements for a "ready test". The user neither has to dissolve reagents nor has he to mix various solutions exactly or to convey the prepared reagent-sample mixture to a measuring vessel. He merely has to introduce into the vessel the accurately measured sample to be analysed and this may be carried out easily, for example by means of volumecalibrated glass capillary tubes, and the vessel may then be conveyed to the photometer.
Possible sources of error which may arise in such operations are thus eliminated from the beginning and the process of analysis is simplified in such a way that even untrained personnel are able to carry out analysis correctly.
Unfortunately, there are, however, only a few reagents for biochemical, haematological and clinico-chemical analyses which remain for prolonged periods (6 months) in a usable state.
This applies in particular to the modern enzymatic methods, as for example, for determining the blood sugar level using glucoseoxidase/peroxidase, hexokinase/glucose-6phosphate-dehydrogenase or glucose-dehydrogenase-mutarotase, for the enzymatic determination of uric asid, urea, triglyceride and cholesterol and, of course, for determining the activity of enzymes themselves.
However, reagents for non-enzymatic determination often do not remain usable over a prolonged period (6 months). This applies, for example, in the determination of bilirubin using diazotized sulphanilic acid according to
Jendrassik and Grof [2] or using 2,5-dichlorophenyl-diazonium salt according to Wahlefeld et al [3], similarly in determining creatinin using picric acid/NaOH according to Popper petal [4] .
The use of single use measuring vessels is accompanied by further problems. Glass is ruled out as material for the single use measuring vessels since glass vessels are much too expensive in the quality required for photometric measurements.
The use of plastics, for example polystyrene, does allow inexpensive mass production of the single use measuring vessels but is frequently accompanied by problems with regard to the durability of the reagents.
Polystyrene is not absolutely impermeable to water vapour and if no suitable premature means are found, the volume of the reagent fluid may alter in the sealed vessel during the storage period. In view of the fact that the analyses to be carried out are dependant upon the mixing ratio being accurately known, false results would thus be obtained.
Polystyrene is also permeable to many gases.
This would be detrimental, for example to the durability of the reagent for determining haemoglobin as haemiglobin cyanide. This reagent contains, in addition to a buffer substance and a detergent for haemolysis of the erythrocytes, pottassium hexacyanoferrate (III), which oxidises haemoglobin to haemiglobin and KCN which converts the haemiglobin into haemiglobin cyanide. The haemiglobin cyanide is subsequently determinec photometrically.
The KCN contained in the reagent is in equilibrium with HCN in the volume of gas above the fluid. HCN may however diffuse through the polystyrene wall of the vessel so that the CN content of the reagent decreases with a half-life period of about 4 weeks. The reagent is not therefore sufficiently durable for marketing.
An object of the invention is accordingly, to overcome the problems of service life described above and to develop "ready tests" with which ready-prepared plastic single use vessels may be used allowing the user to obtain correct analytical results in a short period without additional instruments, as for example, pipettes and without special training.
According to the invention there is provided an apparatus for preparing a fluid for examination in optical analytic instruments comprising a sealed vessel containing an accurately prepared reaction solution and a capillary tube which is insertable into the vessel for dispensing a sample fluid into the reaction solution, wherein in order to regulate the optical properties of the fluid for examination at least one of the reactants required for the formation of the said fluid for examination from the said reaction solution is located in the solid phase in the said capillary tube used for dispensing the sample fluid and/or in a second capillary tube for introduction into the vessel.
The reactants are preferably placed on the internal wall of the capillary tube in a finely divided form.
In this way, the spectrum of the reactants may be enlarged considerably. Frequently, all the reactants cannot be stored together in one solution since they become unstable within a short period or react with each other in this form. This problem is neatly solved by storing such unstable components in the capillary tubes. Reactions previously considered unsuitable for the analytical process described in German Offenlegungsschrift
No. 2,422,260 owing to the unstability of the reactants may thus be achieved. The capillary tubes coated with one reactant and stored dry may remain stable for long periods (more than 6 months) while the reactants which are stable in the solution may be accurately prepared and fed into the measuring vessel.
The technician can now: a) Take up the sample )fluid, blood, plasma,
serum) with the capillary tube coated on its
internal surface and introduce the filled
capillary tube into the plastics single use
vessel. The complete reagent has thus been
formed in a very simple and rapid operating
stage and the sample to be analysed has
been dispensed accurately. After a reaction
period, if required, the sample may be
analysed in a measuring instrument (for
example a photometer).
In this case, the capillary tube must, of
course, be calibrated in volume and the
component of the reagent applied to the
internal surface of the capillary tube must
not falsify the full volume.
b) Introduce the capillary tube coated on the
internal surface into the ready prepared
plastics single use measuring vessel thus
forming the complete reagent. The sample
to be analysed (fluid, blood, plasma, serum)
may then be added (for example using a
volume-calibrated capillary tube). After a
reaction period, if required, the sample
may be analysed in a measuring instrument
(for example, a photometer). If a control
value for the reagent has to be determined
during the test, then this may be obtained
before adding the sample to be analysed.
If a control value for the sample is to be
determined, it is preferable if the sample is
introduced first into the ready prepared
plastics single use measuring vessel, the
control value is determined, the complete
reagent is formed by adding the coated
capillary tube and then the analytical value
is determined. Both the sample control
value and the analytical value may thus be
determined in one plastics single use measu
ring vessel. This saves the use of an extra
vessel and that amount of sample which
would otherwise be necessary for determin
ing the sample control value.
c) Take up another unstable component, for
example an enzyme suspension or the
suspension of an enzyme mixture, using the
capillary tube coated on its internal surface,
and introduced this into the ready prepared
plastics single use measuring vessel thus
forming the complete reagent.
The sample may be added before or after
adding the unstable components depending
upon whether a reagent control value or
a sample control value has to be determined.
The process described under (a) has proved particularly successful, for example, when determining the haemoglobin as haemoglobin cyanide.
1.25 ml of the reagent which is complete apart from the KCN are fed into the plastics single use measuring vessel. The KCN (70 ,ug per capillary tube) is located, in a finely divided state, on the internal surface of a 5 ul capacity volume-calibrated capillary tube. The sample, blood in this case, is taken up by this capillary tube. The capillary is automatically filled by capillary action as soon as it is placed in contact with the blood. The KCN dissolves immediately in the blood and does not measurably affect the accuracy of sample dispensing. Once the capillary tube has filled with blood, it is introduced into the plastics single use measuring vessel. The contents of the capillary tube are mixed with the contents of the vessel by lightly shaking the measuring vessel and the reagent is simultaneously completed.
After a reaction period of 3 minutes, the haemoglobin content of the sample may be determined directly in a photometer.
The method described under (b) has proved particularly successful when determining bilirubin using 2,5-dichlorophenyl-diazonium salts according to Wahleseld et al [3] . During this determination, a sample control value must be taken into consideration. Since a relatively large quantity of sample material is required for determining the bilirubin 50 ijl of serum each content (the sample control and the analysis volumes requiring it is particularly adventageous for the sample control value and analysis value determinations to be adapted so that they can be obtained in one measuring vessel (i.e. with 50 ul of sample).
1.25 ml of reagent which is complete except for the 2,5-dichlorodiphenyl diazonium salt are fed into the plastics single use measuring vessel. The sample (for example 50 ul of serum) is added to the vessel using a capillary tube, and the vessel is lightly shaken. The reagent control value can then be determined in a photometer. The capillary tube on whose internal surface is located the 2,5-dichloropheny diazonium salt, is subsequently introduced into the vessel and it is lightly shaken. The analytic value is determined in the photometer after the reaction period (10 minutes). The result, the bilibubin content of the sample, is obtained by subtracting the sample control value from the analytical value and multiplying the difference by a fixed factor.
The method described under (c) is
preferably used if several components required for the determination are unstable in solution, as for example, in the enzymatic cholesterol determination according to Rschlau et al. [5] with subsequent colour reaction according to Trinder [6]. 1.5 ml of a phosphate buffer/phenol/methanol/hydroxy-polyethoxy dodecane mixture are located in the sealed plastics single use measuring vessel.
4-amino phenazone reacts with phenol and with the H2 02, formed during the enzymatic reaction of the cholesterol to give a colour component (4-(p-benzoquinone-monoimino) phenazone), which is determined photometrically.
4-amino phanazone is located in solid form on the internal surface of a glass or plastics capillary tube, since it forms in solution with phenol, even during storage,the colour component to be determined after the enzymatic reaction.
The capillary tube coated with 4-amino phenazone is now used for introducing the enzyme mixture suspended in, for example, ammonium sulphate (about 20 ul of cholesterol esterase/cholesterol oxidase/peroxidase) into the plastics single using measuring vessel. The contents of the capillary tube are mixed with the contents of the vessel by light shaking and the regent control value is then determined photometrically. The sample to be analysed (fluid, serum, plasma) is now added with a volume-calibrated capillary tube, (for example 10 ,us), the vessel is lightly shaken and the analytical value determined in the photometer after a reaction period of about 15 minutes.
The result, the cholesterol content of the sample, is obtained by subtracting the reagent control value from the analytical value and by multiplying the difference by a fixed factor.
The invention described has made it possible for the first time to offer vessel "ready tests" for haemotological, clinico-chemical and biochemical investigations which, unlike the commercially available "mono-tests", "single glass tests" or "single tests" are actual "ready tests".
The use of measuring vessels of the invention allows the same vessel to be used for preparing the sample and for measurement. The user therefore no longer needs to mix the sample with the reagent in a special reaction vessel and to subsequently convey it to the measuring vessel.
This means both a saving in cost (no reaction vessels required) and a simplification in operation.
Since the measuring vessels contain all liquid constituents of the reaction solution, in exact quantities and the unstable components are located, in exact quantities, on the internal surface of a capillary tube (glass or plastic), the reaction solution may be completed easily and simply by inserting the capillary tube into the plastics single use measuring vessel. Errors when measuring out and dissolving the unstable components are thus eliminated. The user does not have to carry out stages using a pipette.
Analysis may thus be carried out more simply, more rapidly and more accurately.
The applying of the unstable components to the internal surface of a capillary tube has particular advantages:
Small amounts (micrograms) may be introduced exactly into the capillary tube and contained.
Additives are not required (for example fillers and binders required in the production of tablets) which might interfere with the reactions which are frequently sensitive to additives.
The unstable component is guaranteed to dissolve rapidly (about 1 minute) since there are no additives, while tablets require, for example, 10 minutes for complete dissolution.
Turbidity is often produced by additives and renders photometric analysis more difficult is avoided.
Dangerous materials are prevented from coming into direct contact with the skin (fingers).
The durability of the tests is considerably increased since even unstable components in a reaction solution, when stored dry and cool, often last for years.
The reaction period may be reduced and thus also the analysis period. Thus, for example, when determining the haemoglobin by the haemoglobin cyanide method, the pH value of the solution is regulated to 7.2. This is a compromise between the reaction velocity which decreases as the pH value of the solution increases and the durability of the solution which increases as the pH value increases because HCN is driven out of the solution more rapidly at a lower pH value and the reaction solution therefore rapidly becomes unusable.
The reaction period amounts to 3 minutes at a pH value of 7.2.
At a pH value of 6.8 the reaction period only amounts to 1 minute but the solution is no longer stable for a prolonged period.
However, if a capillary tube coated internally with KCN is used, then the pH value of the solution may be regulated to, for example, 6.8 with good stability and the reaction period may thus be clearly reduced.
Since no auxiliary agents such as pipettes or measuring cylinders are required for completing the reagents of these vessel ready tests, these tests are ideally suited to a mobile use, for example, in a rescue helicopter, ambulance or during home visits, particularly since a portable battery-operated photometer (Compur mini-photometer M 1000) is available for these tests.
The use of the plastics single use measuring vessels also affords an advantage with regard to cost. On the one hand, no additional instruments such as pipettes, sample containers or reaction containers are required and, on the other hand, only quantity of that measuring fluid required for the vessel "ready test'' is formed by adding the unstable component and thus no expensive reagents have to be rejected (for example, owing to lack of stability).
As a result of the simplified operation errors are avoided and it is therefore not necessary to carry out repeat analyses.
Owing to the simplified operation which substantially reduces the possibilities of error, people who have not been specially trained may also carry out and obtain correct results for the analyses. These tests may thus also be carried out if there are no specially trained personnel available (for example, during night duty when there are no medical technical employees available, in developing countries).
The opportunity to have people who have not been specially trained to perform these vessel "ready tests" allows further financial saving.
With reference to the accompanying drawings.
A vessel composed of glass or plastic shown diagrammatically in the drawing serves as a measuring vessel. It is filled about half full with a reaction solution 1 and is hermetically sealed at its upper end by a cap 2. The cap 2 serves at the same time as a handle for the vessel so that it is not contaminated when being grasped. There is a pin 3 with a set point of fracture 4 on the cap 2. If the pin 3 is broken off laterally, then a circular hole is produced in the surface of the cap. Capillary tubes 5 and 6 may be inserted through this hole. The capillary tube 5 serves, for example, for dispensing the fluid sample. The capillary tube 6 is coated on its inner face with a reactant in solid form. Instead of taking the form of a coating, the solid reactant may also fill out the volume of the capillary tube in a loose fill.
When the capillary tubes 5 and 6 are introduced and the vessel is shaken vigorously, the contents of the capillary tube 5 and the reactant in the capillary tube 6 are transferred to the reaction solution 1. The capillary tubes 5 and 6 are also brought into the corners of the vessel as a result of the forces of adhesion and do not therefore interfere with the optical path of rays in- the photometer. It is conceivable for both capillary tubes 5 and 6 to be coated internally with various reactants, in which case the capillary 5 is at the same time used for dispensing the sample. There is, furthermore, the possibility of operating with only one capillary tube. In this case, the capillary tube 5 used for dispensing the sample is at the same time the carrier for a reactant.
Commercial instruments of the type described, for example, in German Auslegeschrift
No. 2,338,206 may be used as the photometer.
EXAMPLES
A)Determination of haemoglobin by the
haemoglobin cyanide method
In this case, haemoglobin is oxidised to
haemiglobin by means of potassium hexacyan
oferrate (III) and the haemiglobin is con
verted into haemiglobin cyanide by means
of potassium cyanide.
The quantity to be measured is the extinction
produced by the haemiglobin cyanide at a
wavelength from 540 to 546 nm.
Instruments: Spectral or filter photometer
with measuring wavelength of
540 or 546 nm.
Reagents: Plastics single use measuring
vessels with lid.
Thickness of layer: 1.00 cm; content: 1.25 of reagent having the
following composition:
0.6 mmol/l of potassium hexacyanoferrate (III) 2.5 mmol/l of phosphate buffer pH 7.2 (or
pH 6.8)
1.5 mmol/l of sodium chloride
0.05% of detergent (for example, Saponin)
Volume-calibrated glass capillary tubes
with 5 p1 content (length: 32 mm; internal
diameter 0.446 mm), which are coated in
ternally with 70 pg of KCN.
Method
The set point of fracture 4 in the lid 2 of the plastics simple use measuring vessel is broken by means of the pin 3 provided for that purpose. 5 pl of blood are taken, for example, from a drop of blood from the fingertip or from a sample vessel containing the blood by means of the volume-calibrated glass capillary tube. Any blood which may remain on the exterior of the capillary tube is stripped off and the blood-filled capillary tube 5 is inserted into the vessel. The opening formed in the lid 2 is sealed by an adhesive label. The blood is mixed with the reagent 1 by shaking the measuring vessel, taking care that the measuring vessel is handled only on the lid and on the base so that the walls of the vessel (measuring faces) are not contaminated. After the reaction period (three minutes at pH 7.2, one minute at pH 6.8) the extinction produced by the analysis may be compared with that obtained from a plastics single use measuring vessel which has not yet been used (= reagent control value) in the photometer. The result, the haemoglobin concentration of the blood, is obtained in grams of haemoglobin per 100 ml of blood by multiplying the extinction by 36.8
Production of the capillary tubes coated
internally with KCN
70 mg of KCN are dissolved in 5 ml of a suitable solvent (for example methanol or ethanol). The capillary tubes 5 are filled by immersion in this solution. The solvent is drawn off under a slight vacuum and the
KCN is thus evenly distributed on the internal surface of the capillary tube. When stored dry, the contents of these capillary tubes are stable for at least 12 months.
If the plastics single use measuring vessels are packed so as to be impermeable to water vapour (for example, by sealing in deep-drawn aluminium foil), then their contents are also stable for at least twelve months with constant volume.
The range of measurement and sensitivity of determination correspond completely to the reference method described in the German
Provision DIN Standard No. 58931.
The correctness and accuracy of measuremen were checked by analysing control blood several times (4 C of Coulter-Counter, CH 60 of
Merz and Dade). As shown in Table 1 (appendix), the same results were obtained when determining the haemoglobin using the "ready" vessels of this invention as when determining the haemoglobin using the haemoglobinometer produced by Coulter Electronics GmbH.
The regression line y=0.9669 x + 0.3570 (y = "ready" vessel;x = haemoglobinometer) and the coefficient of correlation r = + 0.9985 were calculated from the results of the comparative experiment carried out on 40 samples of human blood. According to these values, there was a very close correlation between the two methods.
B) Determination of bilirubin using 2,5-dichloro
phenyl-diazonium salts.
In this determination, the total bilirubin is coupled with 2,5-dichloropheynl diazonium chloride to form the corresponding azobilirubin.
Indirect bilirubin is liberated by a detergent.
The quantity to be measured is the extinction, produced by azobilirubin at a wavelength of 546 nm.
Instruments: Spectral or filter photometer
with measuring wavelength
of 546 nm.
Reagents: Plastics single use measuring
vessels with lid.
Thickness of layer: 1.00 cm; Content: 1.25
ml of reagent having
the following com
position:
0.1 N of hydrochloric acid
1% of detergent
Volume-calibrated glass capillary tubes
with 20 pl content (length 30 mm; internal
diameter 1.302 mm), coated on the internal
surface with 2,6-dichlorophenyl diazonium
chloride.
Volume-calibrated glass capillary tubes
(50 /11) for dispensing the sample.
Method
The desired product of fracture 4 in the lid 2 of the plastics single use measuring vessel is broken by means of the pin 3 provided for this purpose. 50 /ll of sample, for example, serum or plasma, are introduced into the measuring vessel using a volume-calibrated glass capillary tube 5. Once the opening in the lid has been sealed with the adhesive label, the sample is mixed with the reagent by lightly shaking the measuring vessel. In so doing, care must be taken that the measuring faces are not touched. The extinction obtained for the measuring vessel (E1 = sample control value) is now determined in the photometer.
The glass capillary tube 6 containing the 2,5-dichlorophenyl diazonium chloride is subsequently introduced into the measuring vessel and the vessel is shaken lightly until the 2,5-dichlorophenyl diazonium chloride has dissolved (about 15 seconds). After the reaction period (at least 10 minutes at room temperature) the extinction for the analysis (E2) is determined in the photometer.
The result, the concentration of the total bilirubin present, is obtained in milligrams per 100 ml of sample (serum or plasma) by subtracting the sample control value (eel ) from the analysis value (E2) and multiplying the difference by 44.5.
Production of the capillary tubes coated
internally with 2,5-dichlorophenyldiazon
ium chloride
125 mg of 2,5-dichlorophenyl diazonium chloride are suspended in 10 ml of a suitable fluid (for example ether). 20 pl volumecalibrated glass capillary tubes are filled by immersion in this solution. The fluid is drawn off under a slight vacuum. The 2,5-dichlorophenyl diazonium chloride is th
of reagent having the following
composition:
0.4 mmol/l of potassium phosphate buffer
pH 7.7
10 mmol/l of phenol
1.8 mmol/l of methanol 0.4% of hydroxypolyethoxydodecane 20 pal volume-calibrated glass capillary tubes
(length 32 mm, internal diameter 0.892),
coated on the internal surface with 4-amino
phenazone. Volume-calibrated glass capillary
tube (20 pI) for dispensing the sample.
Enzyme mixture in 3.2 M of ammonium
sulphate solution composed of
20 U/ml of cholesterol esterase
6 U/ml of cholesterol oxidase
4 U/ml of peroxidase
Method
The set point of fracture in the lid of the plastics single use measuring vessel is broken by means of the pin provided for this purpose.
20 pal of the enzyme mixture are introduced into the measuring vessel using the volumecalibrated glass capillary tube coated with 4aminophenazone on the internal surface, and are mixed with the contents by light shaking.
The complete reagent for determination of the cholesterol is thus formed. The extinction produced by the measuring vessel (El = reagent control value) is now determined in a photometer. 20 pl of the sample (serum or plasma) are subsequently introduced into the measuring vessel using a volume-calibrated glass capillary tube and mixed with the reagent by light shaking. Upon completion of the reaction period (at least ten minutes at room temperature), the extinction for the analysis (E2) is determined in the photometer.
The result, the concentration of the cholesterol, is determined in milligrams per 100 ml of sample (serum or plasma) by subtracting the reagent control value (E1) from the analysis value (E2) and multiplying the difference by 652.
Production of the capillary tube coated
internally with 4aminophenazone 457 of 4-aminophenazone are dissolved in 20 ml of a suitable fluid (for example dichloromethane or benzene). 20,us volume-calibrated glass capillary tubes are filled by immersion in this solution. The fluid is drawn off under a slight vacuum at 600 C. The 4-aminophenazone is thus evenly distributed on the internal surface of the capillary tubes.
The contents of these capillary tubes are stable for at least 12 months if stored cool and dry.
If the plastics single are measuring vessels are impermeable to water vapour, for example by sealing in deep-drawn aluminium foil, then the contents are stable for at least 12 months with constant volume.
The enzyme mixture is stored in glass containers and is stable for at least 12 months if stored at +40 C.
The range of measurement and sensitivity of determination corresponds to the method described by Röschlau et al. (5).
The correctness and accuracy of measurement were checked by analysing control sera several times. When determining the cholesterol using the ready vessels, results which compared well with the results of cholesterol determination by the method according to Röschlau et al. (5) were obtained, wherein the test packaging cholesterol CHOD
PAP-method according to Boehringer
Mannheim was used.
The regression lines y = 0.9905 x + 2.734 (r = ready vessel; x = cholesterol CHOD-PAP method test package, Boehringer Mannheim) were calculated from the results of the comparative experiments carried out on 40 samples and the coefficient of correlation was r = + 0.9885.
According to these values, a close correlation is formed between the two methods.
D) Enzymatic determination of blood sugar
using glucose oxidase, peroxidase and subsequent colour reaction according to
Trinder (example for several sensitive components in the capillary tube).
With this method, glucose is oxidised by glucose oxidase to form gluconic acid. The H202 thus formed is reacted with phenol and 4-aminophenazone using peroxidase to form the colour component, 4-(p-benzoquinone-monoimino)-phenazone.
The quantity to be measured is the extinction produced by the 4-(p-benzoquinone-monoamino)-phenazone at a wavelength of 546 nm.
Instruments: Spectral of filter photometer
with measuring wavelength
of 546 nm.
Reagents: Plastics single use measuring
vessels with lid
Thickness of layer: Icm.
Contents: 1.5 ml of reagent having the
following composition:
0.1 mmol/l of phosphate buffer pH 7.0
4 mmol/l of phenol
10 pl volume-calibrated glass capillary
tubes (length 10 mm; internal diameter
1.12 mm), coated on the internal surface
with a mixture composed of glucose oxi
dase, peroxidase and 4-aminophenazone.
10 It volume-calibrated glass capillary
tubes for dispensing the sample.
Method
The set point of fracture in the lid of the plastics single use measuring vessel is broken by means of the pin provided for this purpose.
The volume-calibrated glass capillary tube containing the mixture of glucose oxidase, peroxidase and 4-aminophenazone is introduced into the measuring vessel and the complete reagent is thus formed. Immediately afterwards, 10 p1 of sample (for example serum or plasma) are introduced into the measuring vessel using a volume-calibrated glass capillary tube. The contents of the capillary tubes are mixed with the contents of the measuring vessel by light shaking. The extinction produced by the measuring vessel (E1 = reagent control value and sample control value) is subsequently determined in a photometer. Upon completion of the reaction period (at least 20 minutes at room temperature), the extinction for the analysis (E2)-is determined in the photometer.
The result, the glucose concentration, is obtained in milligrammes per 100 ml of sample (serum or plasma) by subtracting the reagent control valve and sample control value (E1) from the analytical value (E2) and by multiplying the difference by 597.
Production of the capillary tubes coated
intemally with glucose oxidase, peroxidase,
4-aminophenazone
500 mg of glucose oxidase (degree of purity If 100 U/mg), 50 mg of peroxidase (degree of purity If 100 U/mg) and 520 mg of 4-aminophenazone are suspended in 10 ml of a suitable solvent (for example acetone or dichloroethane).
10,us volume-calibrated glass capillary tubes are filled by immersion in this suspension. The fluid is drawn off under a slight vacuum and the enzyme and the 4-aminophenazone are thus evenly distributed on the internal surface of the capillary tube.
The contents of these capillary tubes are stable for at least 15 months if stored cool and dry.
If the plastics single use measuring vessels are packed so as to be impermeable to watervapour, for example by sealing in deep-drawn aluminium foil, then the contents are stable for at least 15 months with constant volume.
The determination is linear in the range of from 50 to 400 mg of glucose per 100 ml of sample. The sample has to be diluted at higher glucose concentrations.
The correctness and accuracy of measurement are checked by analysing control sera several times.
When determining glucose using the ready vessels, results were obtained which compare well with the results obtained when using the automated packing glucose GOD-PAP method of Boehringer Mannheim for determining the glucose.
The regression line y = 0.9828 x + 0.7491 (y = ready vessel; x = automatic glucose GOD
PAP package method, Boehringer Mannheim) and the coefficient of correlation r = + 0.9923 are calculated from the result of the comparative experiments carried out on 40 samples.
According to these values, there is a close correlation between the two methods.
E) Enzymatic determination of blood sugar
by the glucose - dehydrogenase method
(example of W test)
With this method, ss-D-glucose. is converted into D-gluconolactone by the glucose-dehydrogenase. In so doing, NAD (nicotinamide adenine dinucleotide = co-enzyme) is reduced to NAPS2. The enzyme mutarotase accelerates the formation of the ss-D-glucose from a-Dglucose. The quantity to be measured is the extinction for the NADH2 at a wavelength of 340 or 366 nm.
Instruments: Spectral or filter photometer
with measuring wavelength of
340 or 366 nm.
Reagents: Plastics single use measuring
vessels with lid.
Thickness of layer: 1 cm; content 1.5 ml
of reagent having the
following composition:
0.1 mmol/l of phosphate buffer pH 7.6 10 pal volume-calibrated glass capillary tubes
(length 10 mm; internal diameter 1.12 mm), coated on the internal surface with a mixture
composed of glucose-dehydrogenase,
mutarotase and NAD.
10 pal volume-calibrated glass capillary tubes
for dispensing the sample.
Method
With this method, a reagent control value (required only once for each packing) is determined. For this purpose, a measuring vessel with buffer is measured against a measuring vessel with buffer and internally coated capillary tube. The extinction difference is the reagent control value (ego).
The sample (for example 10,us of serum or plasma) is introduced into an open measuring vessel and is mixed with the buffer. The sample control value is now determined (E, ) in the photometer. The capillary tube coated internally with glucose dehydrogenase, mutarotase,
NAD is subsequently introduced into the measuring vessel and the content is mixed with the content of the measuring vessel by light shaking. Upon completion of the reaction period (10 minutes at room temperature), the extinction produced by the analysis (E2) is determined in the photometer.
The result, the glucose concentration in milligrammes per 100 ml of sample, is obtained by the following formula: Result=E2-(E1 + E,)x 824 Production of the capillary tubes coated
internally with glucose dehydrogenase,
mutarotase, NAD
100 units of glucose dehydrogenase
3.8 units of mutarotase and
14.6 mg of NAD
are suspended in 10 ml of a suitable solvent (for example dichloromethane or dichloroethane). 10 pal volume-calibrated glass capillary tubes are filled by immersion in this suspension.
The solvent is drawn off under a slight vacuum and the enzymes and the NAD are evenly distributed on the internal surface of the capillary tube.
The contents of these capillary tubes are stable for at least 1 5 months if stored cool and dry.
The contents of the plastics single use measuring vessels, stored so as to be impermeable to water-vapour, also remain usable for at least 15 months. The measuring range and the degree of sensitivity of the determination are comparable with the method described by
Banauch et awl (7).
The correctness and accuracy of measurement were checked by analysing control sera several times.
In determining the glucose content using the ready vessels, results were obtained which compared well with the results obtained in glucose determination according to Banauch (7), wherein the test packing glucose (Gluc
DH method, LV test of Merck was used.
The regression line y = 0.9926 x + 2.4120 (y = ready vessel; x = Merckotest (registered
Trade Mark) Glucose) and the coefficient of correlation r = + 0.9941 were calculated from the results of the comparative experiments carried out on 40 samples.
According to these values, there is a close correlation between the two methods.
F) Determination of the choline esterase
activity by the method according to Ellman
(Example for a kinetic method)
With the method described by Ellman et al (8), the choline esterase splits acetyl thiocholine iodine into acetic acid and thiocholine iodide.
Thiocholine iodide reduces the 5,5'-dithiobis2-nitrobenzoic acid (DTNB) to 5-thio-2-nitrobenzoic acid which is determined photometrically at a wavelength of 405 nm.
The quantity to be measured is the change in extinction produced by the 5-thio-2-nitrobenzoic acid at a wavelength of 405 nm.
Instruments: Spectral or filter photometer
with measuring wavelength of 405 nm and vessel holder
temperature-adjustable to 25 CC.
Reagents: Plastics single use measuring
vessel with lid. thickness of
layer: 1.00 cm; contents: 1.5 ml
of reagent having the following
composition:
50 mmol/l of phosphare buffer pH 7.2
0.1% of Saponin 10 pal volume-calibrated glass capillary tubes
(length 10 mm; internal diameter 1.12 mm),
which are coated on their internal surface
with a mixture of acetyl thiocholine iodide
and DTNB.
5 pl volume-calibrated glass capillary tubes
for dispensing the sample.
Method
Since enzyme activity determination are very markedly dependent upon temperature, the activity of the choline esterase must be determined at exactly 250C. For this purpose, the plastics single use measuring vessel is preheated to this temperature (for example in the temperature-adjustable vessel holder of the photometer) The complete reagent is formed by introducing the capillary tube coated internally with acetyl thiocholine iodide and
DTNB. 5 pal of sample (for example, serum, plasma, or whole blood) are subsequently added using a volume-calibrated capillary tube and are mixed with the reagent by light shaking.
The measuring vessel is placed in the vessel container of the photometer, set at a temperature of 25"C. The initial extinction (E1) is read off after 30 seconds.
E2 is determined exactly 60 seconds later.
E3 is determined another 60 seconds later.
The extinction difference per minute is obtained as average value of E2-E1 and E3-E2 - The result, the activity of the choline esterase in units per millilitre (U/ml), is obtained by multiplying the extinction difference per minute (E E/min) by 22.6.
Production of the capillary tubes coated
internally with acetyl thiocholine iodide
and DTNB
2.25 g of acetyl thiocholine iodide and 150 mg of 5,5'-dithiobis-2-nifrobenzoic acid (DTNB) are suspended in 10 ml of a suitable solvent (for example methanol or ethanol).
10 pal volume-calibrated glass capillary tubes are filled by immersion in this suspension. The solvent is drawn off under a slight vacuum and the acetyl thiocholine iodide and the
DTNB are thus evenly distributed on the internal surface of the capillary tube.
The contents of these capillary tubes are stable for at least 15 months if stored cool and dry.
The plastics single use measuring vessel packed so as to be impermeable to watervapour also lasts for at least 15 months.
The measuring range and sensitivity correspond to the method described by Frank (9).
The correctness and precision were checked by analysing control sera several times. When determining the activity of the choline esterase using the ready vessels, results were obtained which compared well with the results of the choline esterase activity by Ellman et al (8), wherein the choline esterase test package of Boehringer Mannheim was used.
The regression line y = 1.0030, - 0.0210 (y = ready vessels; x = test packaging choline esterase of Boehringer Mannheim) and the coefficient of correlation r = + 0.9963 were calculated from the results of the comparative experiment carried out on 40 samples.
According to these values, there is a close correlation between the two methods.
LITERA TURE: [1] C. STEFFEN:
Photometrische Bestimmung der Eryth
orzytenzahl Arztl. Lab. 5 (1959) 76-77
[2] L. JENDRASSIK et al.: Biochem. Z. 297(1938)81 [3] A.W. WAHLEFELD et al.:
Scand. J. clin. Lab. Invest.
Vol. 29, Suppl. 126 (1972) Abstract
11.12.
[4] H. POPPER et al.:
Biochem. Z. 291 (1937) 354
[5] P. RÖSCHLAU et al.:
9th Int. Congr. on Clin. Chemistry,
Toronto, 1975 Abstr. No. 1
[6] P. TRINDER:
Ann. Clin. Biochem. 6 (1969) 24
[7] D. BANAAUCH et al.: -Z. Klin, Chem. Klin, Biochem.
13(1976)101
[8] Gt. ELLMAN et al.:
Biochem. Pharmacol. 7(1961) 88 [9] G. FRANK:
Z. Analyt. Chem. 279 (1976) 155
WHAT WE CLAIM IS:
1. An apparatus for preparing a fluid for examination in optical analytic instruments comprising a sealed vessel containing an accurately prepared reaction solution and a capillary tube which is insertable into the vessel for dispensing a sample fluid into the reaction solution, wherein in order to regulate the optical properties of the fluid for examination at least one of the reactants required for the formation of the said fluid for examination from the said reaction solution is located in the solid phase in the said capillary tube used for dispensing the sample fluid and/or in a second capillary tube for introduction into the vessel.
2. An apparatus according to Claim 1, wherein the said at least one reactant is applied to the internal wall of the capillary tube, in a finely divided form.
3. An apparatus according to Claim 1 or 2, wherein for determining the haemoglobin concentration of a sample the reaction solution in the vessel comprises a phosphatebuffered potassium hexacyanoferrate (III)/ sodium chloride solution and the capillary tube used for dispensing the sample is coated with potassium cyanide.
4. An apparatus according to Claims 1 or 2, wherein in order to determine bilirubin in the blood, the reaction solution comprises 0.1 N hydrochloric acid and in addition to the capillary tube used for dispensing the blood sample, a second capillary tube is provided which is coated with 2,5-dichlorophenyl diazonium chloride.
5. An apparatus according to Claim 1 or 2, wherein for the determination of cholesterol in serum or plasma, the reaction solution com
prises a potassium phosphate-buffered phenol
methanol solution with the addition of hydroxy
polyethoxy dodecane and in addition to the
capillary tube used for dispensing the serum
or plasma, a second capillary tube coated with
4-aminophenazone is provided for introducing
a mixture of enzymes, consisting of cholesterol
esterase, cholesterol oxidase and peroxidase.
6. An apparatus according to Claim 1 or 2,
wherein for the determination of enzymatic blood sugar in a serum or plasma by the method
according to Trinder, the reaction solution
comprises phosphate-buffered phenol and in
addition to the capillary tube used for dis
pensing the serum or plasma sample, a second
capillary tube is provided which is coated with
a mixture of glucose oxidase, peroxidase and
4-aminophenazone.
7. An apparatus according to Claim 1 or 2,
wherein for carrying out enzymatic blood
sugar determination by the glucose dehydroge
nase method, the reaction solution comprises
a phosphate-buffer solution with a pH value
7.6 and in addition to the capillary tube used
for dispensing the sample a second capillary
tube is provided which is coated with a
mixture of glucose dehydrogenase, mutrotase
and nicotinamide adenine dinuclcotide (NAD).
8. An apparatus according to Claim 1 or 2,
wherein for determining the choline esterase
activity by the method according to Ellman,
the reaction solution comprises a phosphate
buffer solution with a pH value of 7.2 and in
addition to the capillary tube used for dis
pensing the sample a second capillary tube is
provided which is coated with a mixture
composed of acetyl thiocholine iodide and
dithiobis-2-nitrobenzoic acid.
9. An apparatus for preparing a fluid for
examination in optical analytic instruments,
substantially as herein described with reference
to the Examples.
10. An apparatus for preparing a fluid for
examination in optical analytic instruments,
substantially as herein described with reference
to the accompanying drawing.
**WARNING** end of DESC field may overlap start of CLMS **.
Claims (10)
1. An apparatus for preparing a fluid for examination in optical analytic instruments comprising a sealed vessel containing an accurately prepared reaction solution and a capillary tube which is insertable into the vessel for dispensing a sample fluid into the reaction solution, wherein in order to regulate the optical properties of the fluid for examination at least one of the reactants required for the formation of the said fluid for examination from the said reaction solution is located in the solid phase in the said capillary tube used for dispensing the sample fluid and/or in a second capillary tube for introduction into the vessel.
2. An apparatus according to Claim 1, wherein the said at least one reactant is applied to the internal wall of the capillary tube, in a finely divided form.
3. An apparatus according to Claim 1 or 2, wherein for determining the haemoglobin concentration of a sample the reaction solution in the vessel comprises a phosphatebuffered potassium hexacyanoferrate (III)/ sodium chloride solution and the capillary tube used for dispensing the sample is coated with potassium cyanide.
4. An apparatus according to Claims 1 or 2, wherein in order to determine bilirubin in the blood, the reaction solution comprises 0.1 N hydrochloric acid and in addition to the capillary tube used for dispensing the blood sample, a second capillary tube is provided which is coated with 2,5-dichlorophenyl diazonium chloride.
5. An apparatus according to Claim 1 or 2, wherein for the determination of cholesterol in serum or plasma, the reaction solution com
prises a potassium phosphate-buffered phenol
methanol solution with the addition of hydroxy
polyethoxy dodecane and in addition to the
capillary tube used for dispensing the serum
or plasma, a second capillary tube coated with
4-aminophenazone is provided for introducing
a mixture of enzymes, consisting of cholesterol
esterase, cholesterol oxidase and peroxidase.
6. An apparatus according to Claim 1 or 2,
wherein for the determination of enzymatic blood sugar in a serum or plasma by the method
according to Trinder, the reaction solution
comprises phosphate-buffered phenol and in
addition to the capillary tube used for dis
pensing the serum or plasma sample, a second
capillary tube is provided which is coated with
a mixture of glucose oxidase, peroxidase and
4-aminophenazone.
7. An apparatus according to Claim 1 or 2,
wherein for carrying out enzymatic blood
sugar determination by the glucose dehydroge
nase method, the reaction solution comprises
a phosphate-buffer solution with a pH value
7.6 and in addition to the capillary tube used
for dispensing the sample a second capillary
tube is provided which is coated with a
mixture of glucose dehydrogenase, mutrotase
and nicotinamide adenine dinuclcotide (NAD).
8. An apparatus according to Claim 1 or 2,
wherein for determining the choline esterase
activity by the method according to Ellman,
the reaction solution comprises a phosphate
buffer solution with a pH value of 7.2 and in
addition to the capillary tube used for dis
pensing the sample a second capillary tube is
provided which is coated with a mixture
composed of acetyl thiocholine iodide and
dithiobis-2-nitrobenzoic acid.
9. An apparatus for preparing a fluid for
examination in optical analytic instruments,
substantially as herein described with reference
to the Examples.
10. An apparatus for preparing a fluid for
examination in optical analytic instruments,
substantially as herein described with reference
to the accompanying drawing.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2721942A DE2721942C3 (en) | 1977-05-14 | 1977-05-14 | Device for processing a measuring liquid for use in analytical optical devices |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1582224A true GB1582224A (en) | 1981-01-07 |
Family
ID=6009015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB19197/78A Expired GB1582224A (en) | 1977-05-14 | 1978-05-12 | Apparatus for the preparation of a fluid for examination in optical analytic instruments |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS6027375B2 (en) |
AT (1) | AT371253B (en) |
AU (1) | AU514940B2 (en) |
BE (1) | BE866993A (en) |
BR (1) | BR7803016A (en) |
CH (1) | CH637216A5 (en) |
DE (1) | DE2721942C3 (en) |
ES (1) | ES469792A1 (en) |
FR (1) | FR2390724A1 (en) |
GB (1) | GB1582224A (en) |
IT (1) | IT1094667B (en) |
NL (1) | NL190427C (en) |
SE (1) | SE7805408L (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2913889A1 (en) * | 1979-04-06 | 1980-10-16 | Compur Electronic Gmbh | METHOD FOR CRYSTALLINE DEPOSITION OF CHROMOGENES |
DE3024835A1 (en) * | 1980-07-01 | 1982-01-28 | Bayer Ag, 5090 Leverkusen | REAGENT FOR HEMOGLOBIN DETERMINATION |
US4454235A (en) * | 1982-06-01 | 1984-06-12 | Miles Laboratories, Inc. | Capillary tube holder for liquid transfer in immunoassay |
DE19835243A1 (en) * | 1998-08-04 | 2000-02-24 | Lmb Technologie Gmbh | Device and method for determining a hemoglobin value of blood |
JP4094377B2 (en) * | 2002-08-22 | 2008-06-04 | 株式会社アペレ | How to use a measuring cell such as a colorimeter |
JP4170189B2 (en) * | 2003-10-02 | 2008-10-22 | 株式会社アペレ | Measuring cell such as a colorimeter and method of using the same |
CN112881303A (en) * | 2021-01-09 | 2021-06-01 | 吉林大学 | Blood glucose concentration detection method based on hyperspectral imaging technology |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2422260B2 (en) * | 1974-05-08 | 1979-04-12 | Compur-Electronic Gmbh, 8000 Muenchen | Device for the production of a measuring liquid to be optically examined |
-
1977
- 1977-05-14 DE DE2721942A patent/DE2721942C3/en not_active Expired
-
1978
- 1978-05-10 CH CH509678A patent/CH637216A5/en not_active IP Right Cessation
- 1978-05-11 SE SE7805408A patent/SE7805408L/en unknown
- 1978-05-11 AU AU36008/78A patent/AU514940B2/en not_active Expired
- 1978-05-12 AT AT0348578A patent/AT371253B/en not_active IP Right Cessation
- 1978-05-12 NL NLAANVRAGE7805189,A patent/NL190427C/en not_active IP Right Cessation
- 1978-05-12 ES ES469792A patent/ES469792A1/en not_active Expired
- 1978-05-12 BR BR7803016A patent/BR7803016A/en unknown
- 1978-05-12 BE BE2056973A patent/BE866993A/en not_active IP Right Cessation
- 1978-05-12 FR FR7814330A patent/FR2390724A1/en active Granted
- 1978-05-12 JP JP53055743A patent/JPS6027375B2/en not_active Expired
- 1978-05-12 GB GB19197/78A patent/GB1582224A/en not_active Expired
- 1978-05-12 IT IT23384/78A patent/IT1094667B/en active
Also Published As
Publication number | Publication date |
---|---|
ATA348578A (en) | 1982-10-15 |
SE7805408L (en) | 1978-11-15 |
NL7805189A (en) | 1978-11-16 |
FR2390724B1 (en) | 1983-12-30 |
AT371253B (en) | 1983-06-10 |
AU3600878A (en) | 1979-11-15 |
JPS6027375B2 (en) | 1985-06-28 |
BR7803016A (en) | 1979-01-02 |
DE2721942C3 (en) | 1980-02-07 |
NL190427C (en) | 1994-02-16 |
DE2721942A1 (en) | 1978-11-23 |
CH637216A5 (en) | 1983-07-15 |
IT7823384A0 (en) | 1978-05-12 |
FR2390724A1 (en) | 1978-12-08 |
BE866993A (en) | 1978-11-13 |
AU514940B2 (en) | 1981-03-05 |
JPS53141688A (en) | 1978-12-09 |
IT1094667B (en) | 1985-08-02 |
ES469792A1 (en) | 1978-12-16 |
DE2721942B2 (en) | 1979-06-07 |
NL190427B (en) | 1993-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0555045B1 (en) | Improved oxidative coupling dye for spectrophotometric quantitative analysis of analytes | |
US5112490A (en) | Sample filtration, separation and dispensing device | |
US6121050A (en) | Analyte detection systems | |
Curme et al. | Multilayer film elements for clinical analysis: general concepts. | |
US4973549A (en) | Quantitative diagnostic assay employing signal producing agent bound to support and measuring migration distance of detectable signal | |
US3298789A (en) | Test article for the detection of glucose | |
EP0071934B1 (en) | Method for preparing a color stable chromogenic analytical element | |
JP3698696B2 (en) | Biological sample preparation method, biological sample quantification method, and biological sample storage container | |
US4078892A (en) | Novel means and method for diagnostic quantitation of serum or plasma bilirubin | |
EP0243066B1 (en) | Element and method for the determination of creatinine or creatine | |
EP0036563B1 (en) | Bilirubin-resistant composition for the determination of cholesterol, test device containing the composition and method of making the test device | |
JP2611890B2 (en) | Measurement method using dry analytical element and dry analytical element | |
GB1582224A (en) | Apparatus for the preparation of a fluid for examination in optical analytic instruments | |
Driscoll et al. | Discrete automated chemistry system with tableted reagents. | |
US4971918A (en) | Reducible indicator compositions containing pyrogallol derivatives | |
EP0291321A2 (en) | Element and method for determination of creatinine or creatine | |
JP2001255323A (en) | Blood separation instrument, blood separation method, method for preparing living body specimen, method for determining living body specimen and living body specimen preserving container | |
IE47123B1 (en) | Analytical device | |
KR950013952B1 (en) | Reagent for use in the measurement of hydrogen peroxide in sample and making method of the reagent | |
Krug et al. | Enzyme-based fiber-optic device for the determination of total and free cholesterol | |
US5084395A (en) | Reducible indicator compositions containing pyrogallol derivatives | |
US4349351A (en) | Reagent for the determination of haemoglobin | |
JPH04252197A (en) | Assay method for catechol and its product and factor thereof | |
Vadgama et al. | Chemical sensors and biosensors: nearer the patient | |
US5071772A (en) | Device for carrying out extemporaneous quantitative diagnostic tests on whole blood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19980511 |